Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-blind Study of Nitazoxanide Compared to Vancomycin in the Treatment of Clostridium Difficile-associated Disease

NCT00384527 is registered in ClinicalTrials.gov with Romark Laboratories L.C. as lead sponsor.

NCT NCT00384527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00384527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-blind Study of Nitazoxanide Compared to Vancomycin in the Treatment of Clostridium Difficile-associated Disease
Lead sponsor
Romark Laboratories L.C.
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2006
Completion date
October 31, 2007
Enrollment
50 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium infections